Abstract
X-linked dystonia parkinsonism (XDP) is a neurodegenerative disorder that has received significant interest on several fronts. Although much still remains to be elucidated regarding the disease cause, a robust amount of data has been produced in recent years compared to when it was first described in 1976. The debilitating nature of the overlapping dystonia and parkinsonism that characterizes this disorder has fueled much of the interest in unraveling its cause, clinical presentation, symptom progression, treatment and impact on the afflicted patients as well as their caregivers. Having made several significant advances in genetic studies, neuropathology, neurophysiology and clinical characterization, we are entering a new threshold in the study of this disorder, hopefully bringing us closer to potential treatments and possible cures. This review will focus on new information gathered regarding the motor and non-motor features of XDP, deep brain stimulation (DBS) as a potential treatment for XDP and the utility of the recently validated XDP-Movement Disorder Society of the Philippines (MDSP)-rating scale.
Similar content being viewed by others
References
Abejero J, Jamora RD, Vesagas TS et al (2019) Long-term outcomes of pallidal deep brain stimulation in X-linked dystonia parkinsonism (XDP): up to 84 months follow-up and review of literature. Parkinsonism Relat Disord 60:81–86
Aneichyk T, Hendriks W, Yadav R et al (2018) Dissecting the causal mechanism of X-linked dystonia-parkinsonism by integrating genome and transcriptome assembly. Cell 172:897–909
Beste C, Muckschel M, Rosales R et al (2017a) Dysfunctions in striatal microstructure can enhance perceptual decision making through deficits in predictive coding. Brain Struct Funct 222:3807–3817
Beste C, Muckschel M, Rosales R et al (2017b) The basal ganglia striosomes affect the modulation of conflicts by subliminal information - evidence from X-linked dystonia parkinsonism. Cereb Cortex 28(7):2243–2252
Beste C, Muckschel M, Rosales R et al (2017c) Striosomal dysfunction affects behavioral adaptation but not impulsivity - evidence from X-linked dystonia-parkinsonism. Mov Disord 32(4):576–584
Bruggemann N, Heldmann M, Klein C et al (2016) Neuroanatomical changes extend beyond striatal atrophy in X-linked dystonia parkinsonism. Park Relat Disord 31:91–97
Bruggemann N, Domingo A, Rasche D et al (2019) Association of pallidal neurostimulation and outcome predictors with X-linked dystonia parkinsonism. JAMA Neurol 76(2):211–216
Chang WC, Taira T, Jamora RDG et al (2019) First experience with MR-guided focused ultrasound in the treatment of X-linked dystonia-parkinsonism (XDP). Mov Disord 34(suppl 2). https://www.mdsabstracts.org/abstract/first-experience-with-mr-guided-focused-ultrasound-in-the-treatment-of-x-linked-dystonia-parkinsonism-xdpXDP/
De Roxas R, Jamora RD (2019) Cost analysis of the different treatment modalities in X-linked dystonia parkinsonism. Front Neurol 10:500
Domingo A, Lee LV, Brüggemann N et al (2014) Woman with X-linked recessive dystonia-parkinsonism: Clue to the epidemiology of Parkinsonism in Filipino women? JAMA Neurol 71(9):1177–1180
Evidente V, Advincula J, Esteban R et al (2002a) Phenomenology of “Lubag” or X-linked dystonia-parkinsonism. Mov Disord 17(6):1271–1277
Evidente V, Gwinn-Hardy K, Hardy J et al (2002b) X-linked dystonia (“Lubag”) presenting predominantly with parkinsonism: a more benign phenotype? Mov Disord 17(1):200–202
Evidente V, Nolte D, Niemann S et al (2004) Phenotypic and molecular analyses of X-linked dystonia-parkinsonism (“lubag”) in women. Arch Neurol 61(12):1956–1959
Evidente V, Lyons M, Wheeler M et al (2007) First case of X-linked dystonia parkinsonism (“Lubag”) to demonstrate a response to bilateral pallidal stimulation. Mov Disord 22(12):1790–1793
Graeber M, Muller U (1992) The X-linked dystonia-parkinsonism syndrome (XDP): clinical and molecular genetic analysis. Brain Pathol 2(4):287–295
Jamora RD, Diesta CC, Pasco PM, Lee LV (2011) Oral pharmacological treatment of X-linked dystonia parkinsonism: successes and failures. Int J Neurosci 121(Suppl 1):18–21
Jamora RD, Ledesma K, Domingo A et al (2014) Nonmotor features in sex-linked dystonia parkinsonism. Neurodegener Dis Manag 4(3):283–289
Jamora RD, Cenina AR, Teleg R, Lee LV (2015) Suicidality among patients with sex-linked dystonia-parkinsonism (XDP). Acta Med Philipp 49(1):20–23
Jamora RD, Teleg RA, Cordero CP et al (2018) Levodopa+carbidopa in X-linked dystonia parkinsonism (XDP/DYT3/Lubag): a randomized, double-blind, placebo-controlled trial. Acta Med Philipp 52(6):510–514
Jinnah HA, Alterman R, Klein C et al (2017) Deep brain stimulation for dystonia: a novel perspective on the value of genetic testing. J Neural Transm (Vienna) 124(4):417–430
Kilbane C, Witt J, Galifianakis NB et al (2018) Long-term outcomes of bilateral pallidal deep brain stimulation for X-linked dystonia and parkinsonism. Stereotact Funct Neurosurg 96(5):320–326
Krishna V, Smmartino F, Rezai A (2018) A review of the current therapies, challenges and future directions of transcranial focused ultrasound technology: advances in diagnosis and treatment. JAMA Neurol 75(2):246–254
Kupke KG, Lee LV, Viterbo G et al (1990) X-linked recessive torsion dystonia in the Philippines. Am J Med Gen 36(2):237–242
Kupke KG, Graeber MB, Muller U (1992) Dystonia-parkinsonism syndrome (XDP) locus: flanking markers in Xq12-q21.1. Am J Hum Genet 50:808–815
Lee LV, Pascasio F, Fuentes F, Viterbo G (1976) Torsion dystonia in Panay, Philippines. Adv Neurol 14:137–151
Lee LV, Kupke KG, Caballar-Gonzaga F, Hebron-Ortiz M, Muller U (1991) The phenotype of the X-linked dystonia-parkinsonism syndrome. An assessment of 42 cases in the Philippines. Medicine (Baltimore) 70(3):179–187
Lee LV, Rivera C, Teleg RA et al (2011) The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, “Lubag”). Int J Neurosci 121:3–11
Makino S, Kaji R, Ando S et al (2007) Reduced neuron-specific expression of the TAF-1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet 80:393–406
Morigaki R, Nakataki M, Kawarai T et al (2013) Depression in X-linked dystonia-parkinsonism: a case-control study. Parkinsonism Relat Disord 19(9):844–846
Pasco PM, Jamora RD, Rosales R et al (2017) Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism. NPJ Parkinsons Dis 3:24
Pauly M, Lopez M, Westenberger A et al (2020) Expanding data collection for the MDSGene database: X-linked dystonia-parkinsonism as use case example. Mov Disord 35(11):1933–1938
Rakovic A, Domingo A, Grütz K et al (2018) Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism. Mov Disord 33(7):1108–1118
Rosales RL (2010) X-linked dystonia parkinsonism: clinical phenotype, genetics and therapeutics. J Mov Disord 3:32–38
Rosales RL, Ng AR, delos Sanots MM, Fernandez HH (2011) The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport) injections for oromandibular, lingual, and truncal-axial dystonias. Int J Neurosci 121(Suppl 1):44–56
Westenberger A, Reyes CJ, Saranza G et al (2019) A hexanucleotide repeat modifies expressivity of x-linked dystonia parkinsonism. Ann Neurol 85:812–822
Wilhelmsen K, Weeks D, Torbjoern G et al (1991) Genetic mapping of “Lubag” (X-linked dystonia parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome. Ann Neurol 29:124–131
Acknowledgments
The authors would like to thank Dr. Aloysius Domingo for information provided regarding patient demographic and clinical presentation and Ms Michelle Joya-Tanglao of CNS-Metropolitan Medical Center for data collation. We are indebted to our patients and their families for their important contribution to this present work. Likewise, we express our sincere appreciation to our esteemed colleagues who kindly referred their personal patients to us for further work-up.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest/Competing interests
The authors declare that they have no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ng, A.R., Jamora, R.D.G. & Rosales, R.L. X-linked dystonia Parkinsonism: crossing a new threshold. J Neural Transm 128, 567–573 (2021). https://doi.org/10.1007/s00702-021-02324-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-021-02324-0